IWP
LEGN icon

IAG Wealth Partners’s Legend Biotech LEGN Stock Holding History

IAG Wealth Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.04K Buy
+500
New +$9.53K ﹤0.01% 393

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

IAG Wealth Partners's LEGN Position: Q1 2026 in Review

IAG Wealth Partners opened a new position in Legend Biotech (LEGN) in Q1 2026: 500 shares worth $9.04K. The stake represents ﹤0.01% of the portfolio and ranks #393 among its holdings.

189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • IAG Wealth Partners held 500 shares of Legend Biotech worth $9.04K as of Q1 2026.
  • Legend Biotech was a new IAG Wealth Partners position in Q1 2026.
  • Legend Biotech made up ﹤0.01% of IAG Wealth Partners's portfolio in Q1 2026, its #393 holding.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on IAG Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.